Authors: de Wit, R Roberts, JT Wilkinson, PM de Mulder, PHM Mead, GM Fossa, SD Cook, P de Prijck, L Stenning, S Collette, L

Citation: R. De Wit et al., Equivalence of three or four cycles of bleomycin, etoposide, and cisplatinchemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: A randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group and the medicalresearch council, J CL ONCOL, 19(6), 2001, pp. 1629-1640

Authors: Thomas, D Brada, M Stenning, S

Citation: D. Thomas et al., Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial, J CL ONCOL, 19(2), 2001, pp. 509-518

Authors: Stenning, S Thomas, D Brada, M

Citation: S. Stenning et al., Medical research council adjuvant trial in high-grade gliomas - In Reply, J CL ONCOL, 19(19), 2001, pp. 3998-3999

Authors: Fizazi, K Tjulandin, S Salvioni, R Germa-Lluch, JR Bouzy, J Ragan, D Bokemeyer, C Gerl, A Flechon, A de Bono, JS Stenning, S Horwich, A Pont, J Albers, P De Giorgi, U Bower, M Bulanov, A Pizzocaro, G Aparicio, J Nichols, CR Theodore, C Hartmann, JT Schmoll, HJ Kaye, SB Culine, S Droz, JP Mahe, C

Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657

Authors: Wheeler, T Stenning, S Negus, S Picken, S Metcalfe, S

Citation: T. Wheeler et al., Evidence to support a change in follow-up policy for patients with breast cancer: Time to first relapse and hazard rate analysis, CL ONCOL-UK, 11(3), 1999, pp. 169-173

Authors: Chataway, J Stenning, S Bleehen, N Grant, R

Citation: J. Chataway et al., Use of different outcome measures in randomised studies of malignant glioma can significantly alter the interpretation of time to progression: Reanalysis of the MRC BR2 study, J NEURO-ONC, 43(1), 1999, pp. 87-92